Condition | Sources | Main result | Refs. | ||
---|---|---|---|---|---|
OA | BM | OA rescue by suppressing inflammatory cytokines and also NLRP3 inflammasome activation by MSCs-exosomesin a rabbit model | [167] | ||
IDD | BM | Modulation of endoplasmic reticulum stress and inhibition of excessive nucleus pulposus cell apoptosis by inducing AKT and ERK signaling in rat models by MSCs-exosomes | [168] | ||
Osteoporosis | iPS-MSCs | Recovery of critical-sized bone defects by improved angiogenesis and osteogenesis by MSCs-exosomesin osteoporotic murine models | [169] | ||
ONFH | iPS-MSCs | Inhibition of ONFH by exerting angiogenesis and inhibition of bone loss through the activation of PI3K/ AKT signaling pathway on endothelial cells elicited by iPS-MSCs-exosomesin ONFH mice model | [170] | ||
OA | BM | Promotion of cartilage development and homeostasis through targeting WNT5A in mice by miR-92a-3p-enriched MSCs-exosomes | [122] | ||
OA | ESCs-MSCs | OA rescue by regulation of the synthesis and degradation of chondrocyte ECM in mice models by ESCs-MSCs-exosomes | [118] | ||
RA | BM | Reduction in joint destruction by inhibiting synoviocyte hyperplasia and angiogenesis by MSCs-exosomesin murine models | [124] | ||
Cartilage defect | BM | Induction of cartilage repair in a rabbit model after combination therapy with MSCs-exosomesand hyaluronic acid | [171] | ||
OA | Synovial | Improvement of the proliferation and migration of chondrocytes by Wnt5a and Wnt5b-enriched MSCs-exosomesmediated by YAP activation | [172] | ||
DMD | PL | Reduction in creatine kinase and TGF-β levels and also promotion in utrophin levels in mice models by MSCs-exosomes | [173] | ||
IVD | BM | Alleviation of IVD degeneration by miR-21 enriched MSCs-exosomesthrough inhibition of PTEN and consequently activation of PI3K/ AKT pathway | [174] | ||
OA | BM | Alleviation of damage of the synovial fibroblasts via blocking PTGS2 elicited by miR-26a-5p enriched MSCs-exosomesin OA rat models | [175] | ||
OA | BM | Re-induction of the expression of type II collagen, aggrecan, and also inhibition of MMP-13, ADAMTS5, and iNOS along with inhibition of macrophage activation in mice models by MSCs-exosomes | [176] | ||
OA | AT | Protection of articular cartilage and alleviation of gait abnormalities by inhibition of mTOR in OA mice models by miR-100-5p enriched MSCs-exosomes | [117] | ||
RA | BM | Suppression of fibroblast-like synoviocytes activation, migration, and invasion in vitro and recovery of arthritis and bone lesions in murine models in vivo by miR-320a-enriched MSCs-exosomes | [177] |